The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
DNA damage response (DDR) gene mutations (mut), mut load, and sensitivity to chemotherapy plus immune checkpoint blockade in urothelial cancer (UC).
 
Matt D. Galsky
Stock and Other Ownership Interests - Dual Therapeutics
Consulting or Advisory Role - Astellas Pharma; BioMotiv; Dendreon; Genentech; GlaxoSmithKline; Janssen; Lilly; Merck
Research Funding - Bristol-Myers Squibb (Inst); Dendreon (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - METHODS AND COMPOSITIONS FOR TREATING CANCER AND RELATED METHODS. MOUNT SINAI SCHOOL OF MEDICINE July 2012 Application number: 20120322792
Travel, Accommodations, Expenses - Astellas Pharma; BioMotiv; Dendreon; Merck
 
Andrew V. Uzilov
No Relationships to Disclose
 
Russell Bailey McBride
No Relationships to Disclose
 
Huan Wang
No Relationships to Disclose
 
Vaibhav G. Patel
No Relationships to Disclose
 
John Sfakianos
No Relationships to Disclose
 
Li Wang
No Relationships to Disclose
 
Nicholas Akers
No Relationships to Disclose
 
Gopa Iyer
No Relationships to Disclose
 
David B. Solit
Honoraria - Loxo; Pfizer
Consulting or Advisory Role - Loxo; Pfizer
 
Takuro Saito
No Relationships to Disclose
 
Mireia Castillo-Martin
No Relationships to Disclose
 
Noah M. Hahn
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Inovio Pharmaceuticals; Oncogenex; Pieris Pharmaceuticals
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Heat Biologics (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Oncogenex (Inst); Principa Biopharma (Inst)
 
Sumanta K. Pal
Honoraria - Astellas Pharma; Medivation; Novartis
Consulting or Advisory Role - Aveo; Bristol-Myers Squibb; Exelixis; Genentech; Myriad Pharmaceuticals; Novartis; Pfizer
Research Funding - Medivation
 
Mark T. Fleming
Employment - Virginia Oncology Associates
Speakers' Bureau - Genentech; Medivation/Astellas
Travel, Accommodations, Expenses - Genentech; Medivation/Astellas
 
Ralph J. Hauke
Stock and Other Ownership Interests - Aethlon
Honoraria - Best Doctors, Inc
Research Funding - Amgen (Inst); Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); US Oncology (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending on an immunotherapeutic
Other Relationship - ABIM Subspecialty Board
 
Bojan Losic
No Relationships to Disclose
 
Sacha Gnjatic
Consulting or Advisory Role - B4CC; Third Rock Ventures
Research Funding - Immune Design; Janssen Research & Development
Patents, Royalties, Other Intellectual Property - Patents on NY-ESO-1 immune compositions and peptides.
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Rong Chen
No Relationships to Disclose
 
Nina Bhardwaj
No Relationships to Disclose